Hjem
Elisabeth Farbus bilde

Elisabeth Farbu

Professor
  • E-postelisabeth.farbu@uib.no
  • Besøksadresse
    Haukeland Universitetssykehus Laboratoriebygget, 7. etg. Heis øst
    5009 Bergen
  • Postadresse
    Postboks 7804
    5020 Bergen
Vitenskapelig artikkel
  • Vis forfatter(e) (2023). Neurofilament and Brain Atrophy and Their Association with Cognition in Multiple Sclerosis: A 10-Year Follow-Up Study. Acta Neurologica Scandinavica.
  • Vis forfatter(e) (2023). Impact of extent of resection on outcome from glioblastoma using the RANO resect group classification system: a retrospective, population-based cohort study. Neuro-Oncology Advances (NOA).
  • Vis forfatter(e) (2022). Butterfly glioblastoma: Clinical characteristics, treatment strategies and outcomes in a population-based cohort. Neuro-Oncology Advances (NOA). 1-11.
  • Vis forfatter(e) (2021). Treatment approach and survival from glioblastoma: Results from a population-based retrospective cohort study from Western Norway. BMJ Open. 1-9.
  • Vis forfatter(e) (2021). CSF neurofilament light chain predicts 10-year clinical and radiologic worsening in multiple sclerosis. Multiple Sclerosis Journal, Experimental, Translational and Clinical. 1-10.
  • Vis forfatter(e) (2021). Brain atrophy and clinical characteristics predicting SDMT performance in multiple sclerosis: A 10-year follow-up study. Multiple Sclerosis Journal, Experimental, Translational and Clinical. 1-10.
  • Vis forfatter(e) (2020). Brain atrophy and employment in multiple sclerosis patients: a 10-year follow-up study. Multiple Sclerosis Journal, Experimental, Translational and Clinical. 8 sider.
  • Vis forfatter(e) (2019). Gut microbiota composition during a 12-week intervention with delayed-release dimethyl fumarate in multiple sclerosis – a pilot trial. Multiple Sclerosis Journal, Experimental, Translational and Clinical. 1-13.
  • Vis forfatter(e) (2018). Neurofilaments and 10-year follow-up in multiple sclerosis. Multiple Sclerosis. 1301-1307.
  • Vis forfatter(e) (2016). The influence of coping styles on long-term employment in multiple sclerosis: A prospective study. Multiple Sclerosis. 1008-1017.
  • Vis forfatter(e) (2016). Robert Schumanns høyre hånd. Tidsskrift for Den norske legeforening. 2005-2009.
  • Vis forfatter(e) (2016). Preclinical disease activity in multiple sclerosis: A prospective study of cognitive performance prior to first symptom. Annals of Neurology. 616-624.
  • Vis forfatter(e) (2016). Guillain Barré syndrome-incidence and clinical course in Southern Rogaland, Norway. Clinical neurology and neurosurgery (Dutch-Flemish ed. Print). 33-37.
  • Vis forfatter(e) (2014). MRI evaluation of grey matter atrophy and disease course in multiple sclerosis: An overview of current knowledge. Acta Neurologica Scandinavica. 32-36.
  • Vis forfatter(e) (2014). Health related quality of life in patients recently diagnosed with multiple sclerosis. Acta Neurologica Scandinavica. 21-26.
  • Vis forfatter(e) (2014). Brain atrophy and disability progression in multiple sclerosis patients: a 10-year follow-up study. Journal of Neurology, Neurosurgery and Psychiatry. 1109-1115.
  • Vis forfatter(e) (2013). Chronic inflammatory demyelinating polyneuropathy (CIDP). Acta Neurologica Scandinavica. 48-51.
  • Vis forfatter(e) (2013). Acute ischemic stroke - from symptom recognition to thrombolysis. Acta Neurologica Scandinavica. 57-64.
  • Vis forfatter(e) (2011). Risk of MS is not associated with exposure to crude oil, but increases with low level of education. Multiple Sclerosis. 780-787.
  • Vis forfatter(e) (2011). Ischemic stroke - novel therapeutic strategies. Acta Neurologica Scandinavica. 28-37.
  • Vis forfatter(e) (2009). Is there a need for long-term follow-up in chronic idiopathic polyneuropathy? Acta Neurologica Scandinavica. 347-352.
  • Vis forfatter(e) (2008). The long-term functional status in patients with Guillain-Barre syndrome. European Journal of Neurology. 1332-1337.
  • Vis forfatter(e) (2008). Late-onset familial amyloid polyneuropathy (FAP) VAl30Met without family history. Clinical Medicine & Research. 80-82.
  • Vis forfatter(e) (2007). Post-polio syndrome patients treated with intravenous immunoglobulin: a double-blinded randomized controlled pilot study. European Journal of Neurology. 60-65.
  • Vis forfatter(e) (2007). Post-polio syndrome patients treated with intravenous immunoglobulin. A double blinded randomised controlled study. European Journal of Neurology. 60-65.
  • Vis forfatter(e) (2007). Perceived disability, fatigue, pain and measured isometric muscle strength in patients with post-polio symptoms. Physiotherapy Research International. 39-49.
  • Vis forfatter(e) (2007). Hospital-referred poyneuropathies - causes, prevalences, clinical- and neurophysiological findings. European Journal of Neurology. 603-608.
  • Vis forfatter(e) (2006). EFNS guideline on diagnosis and management of post-polio syndrome. Report of an EFNS task force. European Journal of Neurology. 795-801.
  • Vis forfatter(e) (2005). Lars Hertervig og Carl Fredrik Hill - kreativitet og psykisk sykdom. Tidsskrift for Den norske legeforening. 3450-3453.
Rapport
  • Vis forfatter(e) (2019). Studieplasser i medisin i Norge. Behov, modeller og muligheter. .
Faglig foredrag
  • Vis forfatter(e) (2020). How many medical students and medical schools do a population of 5 mill need? What is the preferred study model? A report from Norway.
Vitenskapelig foredrag
  • Vis forfatter(e) (2015). Evidence of preclinical disease activity­ a prospective study on cognitive and physical performance prior to first symptom of multiple sclerosis.
  • Vis forfatter(e) (2011). Revised EFNS guidelines for diagnosis and management of post-polio syndrome.
  • Vis forfatter(e) (2009). Kasuistikkonkurranse.
Short communication
  • Vis forfatter(e) (2014). Wernicke's Encephalopathy Mimicking Acute Onset Stroke Diagnosed by CT Perfusion. Case Reports in Neurological Medicine.
  • Vis forfatter(e) (2011). En-og-en-halv-syndrom. Tidsskrift for Den norske legeforening. 1653-1653.
  • Vis forfatter(e) (2008). En 64 år gammel kvinne med mellomørebetennelse, miltinfarkt og pareser. Tidsskrift for Den norske legeforening. 1185-1187.
Anmeldelse
  • Vis forfatter(e) (2021). Oversiktlig om tverrprofesjonell samhandling. Tidsskrift for Den norske legeforening. 1-2.
  • Vis forfatter(e) (2020). En hjernereise. Tidsskrift for Den norske legeforening. 1 sider.
Populærvitenskapelig artikkel
  • Vis forfatter(e) (2010). Moderne hjerneslagbehandling. Utposten. 10-13.
Kronikk
  • Vis forfatter(e) (2020). Simulering som læringsmetode. Tidsskrift for Den norske legeforening. 4 sider.
Doktorgradsavhandling
  • Vis forfatter(e) (2009). Long-term functioning and well-being in chronic idiopathic polyneuropathy and Guillain-Barré syndrome.
Vitenskapelig Kapittel/Artikkel/Konferanseartikkel
  • Vis forfatter(e) (2011). Post-polio syndrome. 9 sider.
  • Vis forfatter(e) (2006). Post-polio syndrome. 10 sider.
Sammendrag/abstract
  • Vis forfatter(e) (2011). The Risk of Multiple Sclerosis Among Petroleum Workers Exposed to Crude Oil and Other Hydrocarbons. Epidemiology. S60-S60.
  • Vis forfatter(e) (2011). Revised EFNS guidelines for diagnosis and management of post-polio syndrome. Journal of Rehabilitation Medicine. 12.
Poster
  • Vis forfatter(e) (2016). Neurofilament light chain and disease progression in MS.
  • Vis forfatter(e) (2008). The long-term outcome of patients with Guillain-Barré syndrome.
Vitenskapelig oversiktsartikkel/review
  • Vis forfatter(e) (2016). Wake-up stroke—Amendable for thrombolysis-like stroke with known onset time? Acta Neurologica Scandinavica. 4-10.
  • Vis forfatter(e) (2016). Radiological imaging in acute ischaemic stroke. European Journal of Neurology. 8-17.
  • Vis forfatter(e) (2010). Update on current and emerging treatment options for post-polio syndrome. Therapeutics and Clinical Risk Management. 307-313.

Se fullstendig oversikt over publikasjoner i CRIStin.